Nightingale Activates Better Health

User-Friendly Technology for Patients.
Perfectly Distilled Information for Providers.

Learn More

Meet the ADAMM Wearable

A small, flexible device that uses medical-grade adhesives to adhere to the user's upper torso. Patients benefit from cutting-edge technology, using the world’s first ambulatory cough monitor ADAMM, which detects:

Meet the ADAMM Wearable
Cough
Cough
Heart Rate
Heart Rate
Presence of Wheeze
Presence of Wheeze
Respiration Rate
Respiration Rate
Skin Temperature
Skin Temperature
Activity Level
Activity Level

INCREASE PRACTICE REVENUE.
No Upfront Costs. No Extra Staff.

Providers benefit from compact, relevant data obtained from the patients’ ADAMMs to utilize for continuum of care of their COPD and Asthmatic patients. ADAMM allows for remote auscultation during a telemedicine call. ADAMM is the only wearable with dual modality of continuous monitoring and real time auscultation.

– both continuous monitoring, as well as real-time auscultation.

HOW IT WORKS

1 Provider orders Nightingale
2 Patient Orientation with Nightingale Respiratory Therapist
3 ADAMM, a spacer, an optional peak flow meter or OPEP device are mailed to patient
4 Patients can set themselves up on their new device or the Nightingale Team will assist, no provider or medical staff time is required
5 Patients can see their data through the Nightingale app on their mobile device or computer. The medical office will have access to patients' data via the Nightingale Professional Dashboard
6 Our Respiratory Therapists, Certified Asthma Educators and Life Coaches monitor patient data, and engage with the patient at least once per month
7 Patient Engagement: Opt in for personalized text tips and education

TO LEARN HOW NIGHTINGALE RPM CAN BENEFIT YOUR PRACTICE, CONTACT US

Note: ADAMM is a general wellness device that is intended to promote a healthy lifestyle and reduce the impact of chronic diseases such as asthma and COPD. Health Care Originals (HCO), provider of ADAMM and Nightingale is currently pursuing FDA clearance for a future version of ADAMM for expanded remote patient monitoring applications.